131 related articles for article (PubMed ID: 29540533)
41. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Liu J; Han L; Zhu L; Yu Y
Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
[TBL] [Abstract][Full Text] [Related]
42. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
[TBL] [Abstract][Full Text] [Related]
43. Effects of sitosterol and sitostanol on micellar solubility of cholesterol.
Ikeda I; Tanabe Y; Sugano M
J Nutr Sci Vitaminol (Tokyo); 1989 Aug; 35(4):361-9. PubMed ID: 2585153
[TBL] [Abstract][Full Text] [Related]
44. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
[TBL] [Abstract][Full Text] [Related]
45. In vitro effects of sitosterol and sitostanol on mitochondrial respiration in human brown adipocytes, myotubes and hepatocytes.
Nascimento EBM; Konings M; Schaart G; Groen AK; Lütjohann D; van Marken Lichtenbelt WD; Schrauwen P; Plat J
Eur J Nutr; 2020 Aug; 59(5):2039-2045. PubMed ID: 31317217
[TBL] [Abstract][Full Text] [Related]
46. Procoagulant imbalance in patients with non-alcoholic fatty liver disease.
Tripodi A; Fracanzani AL; Primignani M; Chantarangkul V; Clerici M; Mannucci PM; Peyvandi F; Bertelli C; Valenti L; Fargion S
J Hepatol; 2014 Jul; 61(1):148-54. PubMed ID: 24657400
[TBL] [Abstract][Full Text] [Related]
47. Lipid profile and non-cholesterol sterols in obese women's serum after supplementing with plant stanol ester.
Stelmach-Mardas M; Walkowiak J; Zagrodzki P; Grygiel-Górniak B; Przysławski J
Forsch Komplementmed; 2014; 21(3):178-83. PubMed ID: 25060157
[TBL] [Abstract][Full Text] [Related]
48. Study of thermodynamic parameters for solubilization of plant sterol and stanol in bile salt micelles.
Matsuoka K; Nakazawa T; Nakamura A; Honda C; Endo K; Tsukada M
Chem Phys Lipids; 2008 Aug; 154(2):87-93. PubMed ID: 18544343
[TBL] [Abstract][Full Text] [Related]
49. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
[TBL] [Abstract][Full Text] [Related]
50. Serum Pentraxin 3 Fragment as a Noninvasive Marker of Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents.
Hamza RT; Elfaramawy AA; Mahmoud NH
Horm Res Paediatr; 2016; 86(1):11-20. PubMed ID: 27309736
[TBL] [Abstract][Full Text] [Related]
51. Decreased Hepatic and Serum Levels of IL-10 Concur with Increased Lobular Inflammation in Morbidly Obese Patients.
Solleiro-Villavicencio H; Méndez-García LA; Ocampo-Aguilera NA; Baltazar-Pérez I; Arreola-Miranda JA; Aguayo-Guerrero JA; Alfaro-Cruz A; González-Chávez A; Fonseca-Sánchez MA; Fragoso JM; Escobedo G
Medicina (Kaunas); 2024 May; 60(6):. PubMed ID: 38929479
[No Abstract] [Full Text] [Related]
52. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
53. Quantitative determination of cholesterol, sitosterol, and sitostanol in cultured Caco-2 cells by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
Palmgrén JJ; Töyräs A; Mauriala T; Mönkkönen J; Auriola S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):144-52. PubMed ID: 15914100
[TBL] [Abstract][Full Text] [Related]
54. The intrahepatic expression levels of bile acid transporters are inversely correlated with the histological progression of nonalcoholic fatty liver disease.
Okushin K; Tsutsumi T; Enooku K; Fujinaga H; Kado A; Shibahara J; Fukayama M; Moriya K; Yotsuyanagi H; Koike K
J Gastroenterol; 2016 Aug; 51(8):808-18. PubMed ID: 26601667
[TBL] [Abstract][Full Text] [Related]
55. High cholestanol and low campesterol-to-sitosterol ratio in serum of patients with primary biliary cirrhosis before liver transplantation.
Nikkilä K; Höckerstedt K; Miettinen TA
Hepatology; 1991 Apr; 13(4):663-9. PubMed ID: 2010161
[TBL] [Abstract][Full Text] [Related]
56. The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.
Fujiwara M; Eguchi Y; Fukumori N; Eguchi H; Tomonaga M; Yoshioka T; Hyakutake M; Sakanishi Y; Kyoraku I; Sugioka T; Fujimoto K; Kusano M; Yamashita S
Intern Med; 2015; 54(24):3099-104. PubMed ID: 26666594
[TBL] [Abstract][Full Text] [Related]
57. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
58. C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
Zimmermann E; Anty R; Tordjman J; Verrijken A; Gual P; Tran A; Iannelli A; Gugenheim J; Bedossa P; Francque S; Le Marchand-Brustel Y; Clement K; Van Gaal L; Sørensen TIA; Jess T
J Hepatol; 2011 Sep; 55(3):660-665. PubMed ID: 21238518
[TBL] [Abstract][Full Text] [Related]
59. Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.
Lee SW; Lee TY; Yang SS; Tung CF; Yeh HZ; Chang CS
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):45-48. PubMed ID: 29428103
[TBL] [Abstract][Full Text] [Related]
60. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
